Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Synonyms
reductoisomerase, ketol-acid reductoisomerase, acetohydroxy acid isomeroreductase, ilv5p, isomeroreductase, acetohydroxyacid isomeroreductase, ahair, acetohydroxy acid reductoisomerase, ilvc1, acetolactate reductoisomerase,
more
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
2-hydroxy-3-keto acid reductoisomerase
-
-
-
-
acetohydroxy acid isomeroreductase
acetohydroxy acid reductoisomerase
-
-
-
-
acetohydroxy-acid isomeroreductase
-
-
-
-
acetohydroxy-acid reductoisomerase
-
-
-
-
acetolactate reductoisomerase
-
-
-
-
alpha-keto-beta-hydroxylacil reductoisomerase
-
-
-
-
alpha-keto-beta-hydroxylacyl reductoisomerase
-
-
-
-
dehydrogenase, dihydroxyisovalerate (isomerizing)
-
-
-
-
dihydroxyisovalerate dehydrogenase (isomerizing)
-
-
-
-
isomerase, ketol acid reducto-
-
-
-
-
ketol-acid reductoisomerase
-
-
acetohydroxy acid isomeroreductase
-
-
-
-
acetohydroxy acid isomeroreductase
-
-
KARI
-
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(R)-2,3-dihydroxy-3-methylbutanoate + NADP+
(S)-2-hydroxy-2-methyl-3-oxobutanoate + NADPH + H+
2-aceto-2-hydroxybutyrate + NADP+
(2R,3R)-2,3-dihydroxy-3-methylvalerate + NADPH + H+
-
-
-
r
2-acetolactate + NADP+
(2R)-2,3-dihydroxy-3-isovalerate + NADPH + H+
-
-
-
r
2-acetolactate + NADPH
2,3-dihydroxyisovalerate + NADP+
-
-
-
?
hydroxypyruvate + NADPH
glycerate + NADP+
-
-
-
?
(2R)-2,3-dihydroxy-3-methylbutanoate + NADP+
(2S)-2-hydroxy-2-methyl-3-oxobutanoate + NADPH + H+
-
-
-
-
r
(R)-2,3-dihydroxy-3-methylbutanoate + NADP+
(S)-2-hydroxy-2-methyl-3-oxobutanoate + NADPH + H+
2-acetolactate + NADPH
2,3-dihydroxy-3-methylbutanoate + NADP+
-
-
-
-
?
2-acetolactate + NADPH + H+
2,3-dihydroxy-3-methylbutanoate + NADP+
-
-
-
-
?
3-hydroxypyruvate + NADPH + H+
?
-
-
-
-
?
additional information
?
-
(R)-2,3-dihydroxy-3-methylbutanoate + NADP+
(S)-2-hydroxy-2-methyl-3-oxobutanoate + NADPH + H+
-
-
-
r
(R)-2,3-dihydroxy-3-methylbutanoate + NADP+
(S)-2-hydroxy-2-methyl-3-oxobutanoate + NADPH + H+
conformational changes in a plant ketol-acid reductoisomerase upon Mg2+ and NADPH binding, overview
-
-
r
(R)-2,3-dihydroxy-3-methylbutanoate + NADP+
(S)-2-hydroxy-2-methyl-3-oxobutanoate + NADPH + H+
-
-
-
-
r
(R)-2,3-dihydroxy-3-methylbutanoate + NADP+
(S)-2-hydroxy-2-methyl-3-oxobutanoate + NADPH + H+
-
the enzyme performs a two-step reaction of an alkyl migration followed by an NADPH-dependent reduction rection
-
-
r
additional information
?
-
KARI catalyzes two reactions: alkyl migration and reduction. Structure-function relationship, effects of ligand binding, MG2+ and NADPH, on the enzyme conformation, overview
-
-
?
additional information
?
-
-
KARI catalyzes two reactions: alkyl migration and reduction. Structure-function relationship, effects of ligand binding, MG2+ and NADPH, on the enzyme conformation, overview
-
-
?
additional information
?
-
-
structure-biological activity relationship, overview
-
-
?
additional information
?
-
-
structure-activity relationship
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Mg2+
required, KM: 0.00324 mM
Mg2+
required for the alkyl migration reaction, Km is 0.0072 mM, binding structure, overview
Mg2+
-
-
Mg2+
-
required for the alkyl migration reaction step
additional information
the enzyme catalyzes a two-step reaction: an alkyl migration that requires Mg2+, and a reduction reaction involving NADPH. For the reduction reaction, a divalent metal ion is also required, with any of Mg2+, Mn2+, Co2+, or Ni2+ utilized in this role
additional information
-
the enzyme catalyzes a two-step reaction: an alkyl migration that requires Mg2+, and a reduction reaction involving NADPH. For the reduction reaction, a divalent metal ion is also required, with any of Mg2+, Mn2+, Co2+, or Ni2+ utilized in this role
additional information
-
the NADPH reaction step requires a divalent cation, e.g. Mg2+, Mn2+, or Co2+, but in a non-specific manner
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1-aminocarbonylcyclopropanecarboxylate
-
1-cyanocyclopropanecarboxylate
-
1-hydroxycyclopropanecarboxylate
-
cyclopropane-1,1-dicarboxylate
a competitive slow-, tight-binding inhibitor
dimethylmalonate
slow-binding inhibitor
ethylene glycol
exhibits competitive and uncompetitive inhibition
1-aminocarbonyl-cyclopropane carboxylate
-
-
1-carbamoylcyclopropanecarboxylic acid
-
-
1-cyano-cyclopropane carboxylate
-
-
1-cyanocyclopropanecarboxylic acid
-
-
2-(4-benzylpiperazin-1-yl)-N-(3,4-dichlorophenyl)acetamide
-
48.1% inhibition at 200 microg/ml
2-dimethylphosphinoyl-2-hydroxyacetate
-
i.e. Hoe 704, potent competitive inhibitor in vitro but weak in vivo
2-[[(4-methoxyphenyl)carbonyl]amino]benzoic acid
-
57.4% inhibition at 200 microg/ml
4,4'-(pentamethylenedioxy)dibenzamidne bis(2-hydroxyethanesulfonate)
-
binding structure and inhibition mechanism, overview
4-(2,4-dichlorophenoxy)benzenecarboximidamide
-
-
4-(2-fluorophenoxy)benzenecarboximidamide
-
-
4-(3-chlorophenoxy)benzenecarboximidamide
-
-
4-(4-chlorophenoxy)benzenecarboximidamide
-
-
4-phenoxybenzenecarboximidamide
-
-
cyclopropane-1,1-dicarboxylate
-
-
cyclopropane-1,1-dicarboxylic acid
-
-
ethyl [(2-chlorophenyl)(hydroxy)amino](oxo)acetate
-
-
ethyl [hydroxy(2-methylphenyl)amino](oxo)acetate
-
-
ethyl [hydroxy(4-methylphenyl)amino](oxo)acetate
-
-
ethyl [[4-(cyanomethyl)phenyl](hydroxy)amino](oxo)acetate
-
-
methyl [hydroxy(1-methylethyl)amino](oxo)acetate
-
-
N'-(5-(2-chlorophenyl)-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea
-
-
N'-(5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea
-
-
N'-(5-(2-methyl-phenyl)-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea
-
-
N'-(5-(3-methyl-phenyl)-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea
-
-
N'-(5-(3-pyridinyl)-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea
-
-
N'-(5-(4-chlorophenyl)-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea
-
-
N'-(5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea
-
-
N'-(5-(4-nitrophenyl)-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea
-
-
N'-(5-butyl-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea
-
-
N'-(5-ethyl-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea
-
-
N'-(5-furan-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea
-
-
N'-(5-heptyl-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea
-
-
N'-(5-iso-propyl-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea
-
-
N'-(5-isopropyl-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea
-
-
N'-(5-methyl-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea
-
-
-
N'-(5-octyl-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea
-
-
N'-(5-pentyl-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea
-
-
N'-(5-phenyl-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea
-
-
N'-(5-propyl-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea
-
-
N-(5-substituted-1,3,4-thiadiazol-2-yl)-N-cyclopropylformyl-thiourea
-
-
N-Hydroxy-N-isopropyloxamate
N-Hydroxy-N-isopropyloxamate
-
-
N-Hydroxy-N-isopropyloxamate
-
i.e. IpOHA, potent competitive inhibitor in vitro but weak in vivo
additional information
no inhibition by 1-aminocyclopropanecarboxylate, 1-methylcyclopropanecarboxylate, 2-methylcyclopropanecarboxylate, cyclopropane-1,2-dicarboxylate, and cyclopropanecarboxylate dimethyl ester
-
additional information
-
structure-activity relationship
-
additional information
-
computer-aided drug design, overview
-
additional information
-
no inhibition by N'-(5-methyl-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea, N'-(5-ethyl-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea, and N'-(5-propyl-1,3,4-thiadiazol-2-yl)-N-cyclopropyformyl-thiourea
-
additional information
-
high throughput receptor-based virtual screening of the ZINC/drug like database based on the crystal structure of ketol-acid reductoisomerase/N-hydroxy-N-isopropyloxamate complex, PDB entry 1YVE
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.0203
1-aminocarbonylcyclopropanecarboxylate
pH 8.0, 30°C, recombinant enzyme
0.0585
1-cyanocyclopropanecarboxylate
pH 8.0, 30°C, recombinant enzyme
0.0056
1-hydroxycyclopropanecarboxylate
pH 8.0, 30°C, recombinant enzyme
0.0000903
cyclopropane-1,1-dicarboxylate
pH 8.0, 30°C, recombinant enzyme, versus hydroxypyruvate
0.000716
dimethylmalonate
pH 8.0, 30°C, recombinant enzyme
0.0025 - 0.0032
ethylene glycol
0.00002
1-aminocarbonyl-cyclopropane carboxylate
-
-
0.031
1-carbamoylcyclopropanecarboxylic acid
-
pH 8.0, 30°C
0.000058
1-cyano-cyclopropane carboxylate
-
-
0.095
1-cyanocyclopropanecarboxylic acid
-
pH 8.0, 30°C
0.35
4,4'-(pentamethylenedioxy)dibenzamidne bis(2-hydroxyethanesulfonate)
-
-
0.00009
cyclopropane-1,1-dicarboxylate
-
-
0.076
cyclopropane-1,1-dicarboxylic acid
-
pH 8.0, 30°C
0.035
ethyl [(2-chlorophenyl)(hydroxy)amino](oxo)acetate
-
-
0.049
ethyl [hydroxy(2-methylphenyl)amino](oxo)acetate
-
-
0.351
ethyl [hydroxy(4-methylphenyl)amino](oxo)acetate
-
-
1.704
ethyl [[4-(cyanomethyl)phenyl](hydroxy)amino](oxo)acetate
-
-
0.034
methyl [hydroxy(1-methylethyl)amino](oxo)acetate
-
-
0.0027 - 0.00275
N-Hydroxy-N-isopropyloxamate
additional information
additional information
inhibition mechanism and kinetics
-
0.0025
ethylene glycol
pH 8.0, 30°C, recombinant enzyme, competitive mode
0.0032
ethylene glycol
pH 8.0, 30°C, recombinant enzyme, uncompetitive mode
0.0027
N-Hydroxy-N-isopropyloxamate
-
pH 8.0, 30°C
0.00275
N-Hydroxy-N-isopropyloxamate
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Lee, Y.; Ta, H.T.; Duggleby, R.G.
Cyclopropane-1,1-dicarboxylate is a slow-, tight-binding inhibitor of rice ketol-acid reductoisomerase
Plant Sci.
168
1035-1040
2005
Oryza sativa (Q65XK0)
brenda
Wang, B.; Li, Z.; Li, Y.; Wang, S.
Syntheses and biological activities of ethyl N-hydroxy-N-(substituted)phenyloxamates as KARI inhibitors
Chem. Res. Chin. Univ.
23
280-283
2007
Oryza sativa
-
brenda
Wang, B.; Li, Y.; Wang, J.; Ma, Y.; Li, Z.
Molecular design, synthesis and biological activities of amidines as new ketol-acid reductoisomerase inhibitors
Chin. Chem. Lett.
19
651-654
2008
Escherichia coli, Oryza sativa, Spinacia oleracea
-
brenda
Liu, X.H.; Zhang, C.Y.; Guo, W.C.; Li, Y.H.; Chen, P.Q.; Wang, T.; Dong, W.L.; Wang, B.L.; Sun, H.W.; Li, Z.M.
Synthesis, bioactivity and SAR study of N-(5-substituted-1,3,4-thiadiazol-2-yl)-N-cyclopropylformyl-thioureas as ketol-acid reductoisomerase inhibitors
J. Enzyme Inhib. Med. Chem.
24
545-552
2009
Oryza sativa
brenda
Leung, E.W.; Guddat, L.W.
Conformational changes in a plant ketol-acid reductoisomerase upon Mg2+ and NADPH binding as revealed by two crystal structures
J. Mol. Biol.
389
167-182
2009
Oryza sativa (Q65XK0), Oryza sativa
brenda
Liu, X.H.; Chen, P.Q.; Wang, B.L.; Dong, W.L.; Li, Y.H.; Xie, X.Q.; Li, Z.M.
High throughput receptor-based virtual screening under ZINC database, synthesis, and biological evaluation of ketol-acid reductoisomerase inhibitors
Chem. Biol. Drug Des.
75
228-232
2010
Oryza sativa
brenda
Wang, B.; Ma, Y.; Li, Y.; Wang, S.; Li, Z.
The design, synthesis of amide KARI inhibitors and their biological activities
Front. Chem.
4
186-190
2009
Brassica rapa subsp. oleifera, Echinochloa crus-galli, Oryza sativa
-
brenda
Tadrowski, S.; Pedroso, M.M.; Sieber, V.; Larrabee, J.A.; Guddat, L.W.; Schenk, G.
Metal ions play an essential catalytic role in the mechanism of ketol-acid reductoisomerase
Chemistry
22
7427-7436
2016
Escherichia coli, Oryza sativa
brenda